GSK
GSK completes further high-profile staff acquisition
July 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer Senior Vice President of Medicinal Sciences, Tony Wood, has agreed to join GSK, as broken by FierceBiotech. The appointment …
Not long after leaving GSK, Andrew Witty dips toes back into water
July 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, G1 Therapeutics, GSK, biotech, drugs, pharma, pharmaceutical
Only a short while after leaving his position as CEO of GSK, it seems Andrew Witty cannot resist getting back …
GSK signs $43 million AI-based drug discovery deal with Exscientia
July 3, 2017Research and Development, Sales and Marketing AstraZeneca, Exscientia, GSK
With AI partnerships becoming increasingly common in the life sciences industry, it has emerged that GSK is to partner up …
GSK’s new President of Global Pharma join date revealed as AZ drops lawsuit
June 20, 2017Business Services, Manufacturing and Production AZ, AstraZeneca, GSK, GlaxoSmithKline, Luke Miels
The transition of former AstraZeneca Executive Vice President for Europe Luke Miels to rival pharma giant GlaxoSmithKline has not been …
AZ launches lawsuit against former executive for defecting to GSK
May 17, 2017Manufacturing and Production, Research and Development AZ, AstraZeneca, GSK, GlaxoSmithKline
AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …
GSK mulls $8 billion healthcare consolidation deal
May 15, 2017Sales and Marketing GSK, Novartis
When GSK and Novartis first agreed their business swap and healthcare joint venture, it was seen as marking a shift …
GSK boosts Benlysta production with $139 million investment
May 5, 2017Manufacturing and Production, Medical Communications GSK
GSK has announced that it will invest $139 million into increasing production capacity at its Rockville, Maryland, site. The manufacturing …
Teva launches competitors to GSK’s Advair inhaler
April 21, 2017Medical Communications, Sales and Marketing Advair, AirDuo, GSK, Teva, asthma
GSK has been anticipating competition to its Advair for two years and Teva has announced that it will be the …
GSK hit by recall of 600,000 inhalers
April 5, 2017Manufacturing and Production, Research and Development FDA, GSK, Ventolin
The FDA has released that GSK would be voluntarily recalling close to 600,000 of its Ventolin asthma inhalers across the …
Mylan’s generic of best-selling GSK drug delayed by FDA
March 30, 2017Sales and Marketing Advair, GSK, Mylan
Mylan’s plan to bring its generic competitor to GSK’s best-selling respiratory drug, Advair, has hit a major snag after it …
GSK and Regeneron partner with Biobank to analyse 500,000 genetic profiles
March 23, 2017Research and Development Biobank, GSK, Regeneron
GlaxoSmithKline and Regeneron Pharmaceuticals are to band together in a joint effort with UK Biobank – “the world’s most detailed …
GSK begins £92 million expansion of UK site
March 22, 2017Manufacturing and Production, Research and Development GSK, UK
GSK has officially broken ground on the expansion of its site in County Durham. The expanded site will be an …
China’s insurance expansion boon to global pharma
February 23, 2017Sales and Marketing AstraZeneca, China, GSK, Shire
China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …
GSK unveils strong showing for twin-drug HIV treatment
February 14, 2017Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, HIV, Tivicay
GlaxoSmithKline has announced strong Phase 3 findings for its own Tivicay (dolutegravir) as part of a twin-drug regimen with J&J’s …
Major pharma firms join Liverpool Uni in £14m pharmacovigilance project
January 30, 2017Research and Development, Sales and Marketing AZ, AbbVie, Eli Lilly, GSK, University of Liverpool, pharmacovigilance
The UK’s University of Liverpool is to launch a £14 million pharmacovigilance project focused on using new modelling approaches to …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
